Check out three ways to overcome information manager challenges in 2018.
There is value in the discovery of important information, but it’s a leap to turn curation into a commercial model.
How will the proposed CVS/Aetna merger impact drug R&D?
Top OA issues: the burden of expected author OA expertise; the underutilization of metadata in the publication lifecycle, and the challenges posed to authors and institutions by one-off solutions.
How can life sciences organizations transform large volumes of complex data into hypothesis-generating knowledge representation? Enterprise data science.
Wondering what’s happening with the Fair Access to Science and Technology Research Act (FASTR)? Here’s an update.
Creators’ interests and the public’s interests are mutually reinforcing. Don’t the author and the reader need each other?